Crizotinib companion diagnostic - Abbott

Drug Profile

Crizotinib companion diagnostic - Abbott

Alternative Names: Abbott ALK test; ALK gene rearrangement diagnostic - Abbott; Vysis ALK Break Apart FISH Probe Kit

Latest Information Update: 06 Mar 2017

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Abbott Laboratories
  • Class Diagnostic agents
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Non-small cell lung cancer

Most Recent Events

  • 06 Mar 2017 Launched for Non-small cell lung cancer (Diagnosis) in Taiwan, South Korea, Malaysia, and Japan (unspecified route) before March 2017
  • 06 Mar 2017 No recent reports on development identified - Registered for Non-small cell lung cancer (Diagnosis) in Australia (unspecified route)
  • 30 Aug 2011 Preregistration for Non-small cell lung cancer (diagnosis) in Asia (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top